Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: RVTY )

111.11 -0.23 (-0.21%)
Official Closing Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,374,995
Open 111.38
Bid (Size) 109.51 (1)
Ask (Size) 113.00 (1)
Prev. Close 111.34
Today's Range 109.72 - 114.13
52wk Range 86.30 - 129.50
Shares Outstanding N/A
Dividend Yield 0.25%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK
From Revvity
Via Business Wire
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells
From Scale Biosciences
Via Business Wire

Performance

YTD
+0.62%
+0.62%
1 Month
-6.46%
-6.46%
3 Month
-6.94%
-6.94%
6 Month
-0.70%
-0.70%
1 Year
+24.17%
+24.17%

More News

Read More
Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
From Revvity
Via Business Wire
These Analysts Revise Their Forecasts On Revvity Following Q3 Results
Via Benzinga
Assessing Revvity: Insights From 8 Financial Analysts
Via Benzinga
Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation
From Revvity
Via Business Wire
Revvity Announces Financial Results for the Third Quarter of 2024
From Revvity
Via Business Wire
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Looking Into Revvity's Recent Short Interest
Via Benzinga
4 Analysts Have This To Say About Revvity
Via Benzinga
Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories
From Revvity
Via Business Wire
Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report
From Revvity
Via Business Wire
Revvity To Hold Earnings Call on Monday, November 4, 2024
From Revvity
Via Business Wire
Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene
From Revvity
Via Business Wire
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday?
Via Benzinga
Topics Economy
Exposures Interest Rates
RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 Performance
Via Benzinga
Revvity Announces Financial Results for the Second Quarter of 2024
From Revvity
Via Business Wire
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Revvity To Hold Earnings Call on Monday, July 29, 2024
From Revvity
Via Business Wire
Revvity to Present at Goldman Sachs Global Healthcare Conference
From Revvity
Via Business Wire
RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Revvity Announces Financial Results for the First Quarter of 2024
From Revvity
Via Business Wire
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.